Research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
The Institute Seminar on Wednesday June 19h will ble held by Erik Boye, Scientific Director at the Institute for Cancer Research.
Title of his talk: “Information from the Institute Council”.
Time and place: 12 - 13 in the Auditorium, New Research Building, Montebello.
Important findings from Skjeven, Lødrup Carlsen and coworkers published in New England Journal of Medicine
Håvard Ove Skjerven and Karin C. Lødrup Carlsen (photo) from the Department of Pediatrics at OUS are first and last author of an article published in New England Journal of Medicine (journal impact factor 53.3) June 13th, entitled "Racemic Adrenaline and Inhalation Strategies in Acute Bronchiolitis". In this paper Skjerven, Lødrup Carlsen and coworkers aimed to assess the effectiveness of inhaled racemic adrenaline as compared with inhaled saline and the strategy for frequency of inhalation (on demand vs. fixed schedule) in infants hospitalized with acute bronchiolitis. Their findings has led to changes in the national guidelines, thus improving the treatment of bronchiolits.
Helse Sør-Øst RHF, in cooperation with the University of Oslo, are now announcing research funding opportunities for 2014.
The application deadline is 6th September 2013, 4:00 PM.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of May 2013, this honor goes to Guttorm Haraldsen from the Department of Pathology at the Division of Diagnostics and Intervention at Oslo University Hospital.
Anja Nilsen (photo) from Arne Klungland's group at the Department of Microbiology, Oslo University Hospital, is shared first-author on a collaborative work entitled "ALKBH4-dependent demethylation of actin regulates actomyosin dynamics", recently published in Nature communications.
Rolf Skotheim (photo) is the site responsible in Oslo, and says that across all types of cancer, testicular cancer is now the type for which known susceptibility genes explain the largest fraction the genetic risk.
Jun 17, 2013
Jun 14, 2013
International approaches to personalized cancer medicine
Jun 5, 2013
Selected latest publications
Journ. Impact factor > 8 First or last author from Oslo University Hospital
Racemic adrenaline and inhalation strategies in acute bronchiolitis
N Engl J Med, 368 (24), 2286-93
Sick leave and a smoking ban
Eur Heart J (in press)
More selected publications